OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Small molecular inhibitors for KRAS-mutant cancers
Xuan Wu, Wenping Song, Cheng Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Xuan Wu, Wenping Song, Cheng Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Showing 15 citing articles:
Circular RNAs in the KRAS pathway: Emerging players in cancer progression
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Md Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155259-155259
Closed Access | Times Cited: 12
Targeting RAF dimers in RAS mutant tumors: From biology to clinic
Huanhuan Yin, Qiulin Tang, Hongwei Xia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1895-1923
Open Access | Times Cited: 6
Huanhuan Yin, Qiulin Tang, Hongwei Xia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1895-1923
Open Access | Times Cited: 6
Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Interpretable deep-learning pKa prediction for small molecule drugs via atomic sensitivity analysis
Joseph A. DeCorte, Benjamin P. Brown, Jens Meiler
(2024)
Open Access | Times Cited: 2
Joseph A. DeCorte, Benjamin P. Brown, Jens Meiler
(2024)
Open Access | Times Cited: 2
Cross-attention enables deep learning on limited omics-imaging-clinical data of 130 lung cancer patients
Suraj Verma, Giuseppe Magazzù, Noushin Eftekhari, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 7, pp. 100817-100817
Open Access | Times Cited: 2
Suraj Verma, Giuseppe Magazzù, Noushin Eftekhari, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 7, pp. 100817-100817
Open Access | Times Cited: 2
Structural modifications and kinetic effects of KRAS interactions with HRAS and NRAS: an in silico comparative analysis of KRAS mutants
Isaac Silverman, Michael A. Gerber, Aaron Shaykevich, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Isaac Silverman, Michael A. Gerber, Aaron Shaykevich, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Efficacy and toxicity of KRASG12C inhibitors in advanced solid tumors: a meta-analysis
Shoutao Dang, Shuyang Zhang, Jingyang Zhao, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Shoutao Dang, Shuyang Zhang, Jingyang Zhao, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Untangling sporadic brain arteriovenous malformations: towards targeting the KRAS/MAPK pathway
Rashad Jabarkheel, Lun Li, Maxwell Frankfurter, et al.
Frontiers in Surgery (2024) Vol. 11
Open Access | Times Cited: 1
Rashad Jabarkheel, Lun Li, Maxwell Frankfurter, et al.
Frontiers in Surgery (2024) Vol. 11
Open Access | Times Cited: 1
Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report
Mingxing Wang, Pei Zhu, Yue Shi, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 25, pp. 5805-5813
Open Access
Mingxing Wang, Pei Zhu, Yue Shi, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 25, pp. 5805-5813
Open Access
Investigating Short-Chain Fatty Acids Effects on Extracellular Vesicles Production in Colorectal Cancer
Daniela O. Macedo, Sara Abalde‐Cela, Lorena Diéguez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Daniela O. Macedo, Sara Abalde‐Cela, Lorena Diéguez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Effectiveness and Mechanism of Resibufogenin on Human Renal Cancer Cell Caki-1
Yuqi Wu, Yue Yang, Run Huang, et al.
Biology (2024) Vol. 13, Iss. 12, pp. 1064-1064
Open Access
Yuqi Wu, Yue Yang, Run Huang, et al.
Biology (2024) Vol. 13, Iss. 12, pp. 1064-1064
Open Access
Interpretable Deep-Learning pKa Prediction for Small Molecule Drugs via Atomic Sensitivity Analysis
Joseph A. DeCorte, Benjamin P. Brown, R. Brooke Jeffrey, et al.
Journal of Chemical Information and Modeling (2024) Vol. 65, Iss. 1, pp. 101-113
Open Access
Joseph A. DeCorte, Benjamin P. Brown, R. Brooke Jeffrey, et al.
Journal of Chemical Information and Modeling (2024) Vol. 65, Iss. 1, pp. 101-113
Open Access
KRAS-Degrading Compounds: A Novel Approach to Treat Cancer by Targeting Both Wild-Type and Mutated KRAS Forms
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1493-1495
Closed Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1493-1495
Closed Access
